1. Home
  2. STVN vs MC Comparison

STVN vs MC Comparison

Compare STVN & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • MC
  • Stock Information
  • Founded
  • STVN 1949
  • MC 2007
  • Country
  • STVN Italy
  • MC United States
  • Employees
  • STVN N/A
  • MC N/A
  • Industry
  • STVN Containers/Packaging
  • MC Investment Managers
  • Sector
  • STVN Consumer Discretionary
  • MC Finance
  • Exchange
  • STVN Nasdaq
  • MC Nasdaq
  • Market Cap
  • STVN 5.7B
  • MC 5.0B
  • IPO Year
  • STVN 2021
  • MC 2014
  • Fundamental
  • Price
  • STVN $19.27
  • MC $48.83
  • Analyst Decision
  • STVN Buy
  • MC Hold
  • Analyst Count
  • STVN 7
  • MC 7
  • Target Price
  • STVN $26.93
  • MC $71.83
  • AVG Volume (30 Days)
  • STVN 365.9K
  • MC 1.2M
  • Earning Date
  • STVN 03-06-2025
  • MC 04-23-2025
  • Dividend Yield
  • STVN 0.29%
  • MC 4.92%
  • EPS Growth
  • STVN N/A
  • MC N/A
  • EPS
  • STVN 0.45
  • MC 1.93
  • Revenue
  • STVN $1,143,012,735.00
  • MC $1,194,545,000.00
  • Revenue This Year
  • STVN $8.60
  • MC $28.67
  • Revenue Next Year
  • STVN $12.43
  • MC $17.37
  • P/E Ratio
  • STVN $45.67
  • MC $27.45
  • Revenue Growth
  • STVN 1.72
  • MC 39.75
  • 52 Week Low
  • STVN $16.56
  • MC $46.24
  • 52 Week High
  • STVN $31.41
  • MC $82.89
  • Technical
  • Relative Strength Index (RSI)
  • STVN 41.47
  • MC 26.92
  • Support Level
  • STVN $20.11
  • MC $56.48
  • Resistance Level
  • STVN $21.21
  • MC $60.62
  • Average True Range (ATR)
  • STVN 1.02
  • MC 2.05
  • MACD
  • STVN -0.15
  • MC -0.03
  • Stochastic Oscillator
  • STVN 8.51
  • MC 0.98

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Share on Social Networks: